Abstract: A pharmaceutical composition for the treatment, prevention or diagnosis of a tumoral pathology comprising an active agent which stabilizes an actin network of a cellular cytoskeleton.
Type:
Application
Filed:
December 18, 2003
Publication date:
September 30, 2004
Applicants:
Bioalliance Pharma, a corporation of France, Ecole Normale Superieure de Cachan, a corporation of France, Institut Gustave Roussy - IGR, a corporation of France, Centre National de la Recherche Scientifique - CNRS, a corporation of France
Inventors:
Christian Auclair, Valerie Amsellem, Martial Hervy, Frederic Subra